Gene · 7004
Papers1,824
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,824
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives. | ADMET DMPK | 2025 | 40786064 | PubTator, text mining | PubMed |
| Decoy Extracellular Vesicles Overcome Triple-Negative Breast Cancer Heterogeneity via Membrane-Cytoplasm-Mitochondria Cascade Targeting. | Adv Sci (Weinh) | 2025 | 40755363 | PubTator, text mining | PubMed |
| Integrating single-cell regulatory atlas and multi-omics data for differential treatment response and multimodal predictive modeling in CDK 4/6 inhibitor-treated breast cancer. | Front Oncol | 2025 | 40746611 | PubTator, text mining | PubMed |
| Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2-mutant mesothelioma. | Life Sci Alliance | 2025 | 40744733 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| In silico analysis of UCP promoters predicts conserved and human specific regulators of adipocyte thermogenesis. | iScience | 2025 | 40687843 | PubTator, text mining | PubMed |
| A phylogenetic approach uncovers cryptic endogenous retrovirus subfamilies in the primate lineage. | Sci Adv | 2025 | 40680142 | PubTator, text mining | PubMed |
| Chronic stress: a fourth etiology in tumorigenesis? | Mol Cancer | 2025 | 40676620 | PubTator, text mining | PubMed |
| YAP1 and QSER1 are Key Modulators of Embryonic Signaling Pathways in the Mammalian Epiblast. | bioRxiv | 2025 | 40667326 | PubTator, text mining | PubMed |
| SARS-CoV-2 NSP13 interacts with TEAD to suppress Hippo-YAP signaling. | bioRxiv | 2025 | 40667266 | PubTator, text mining | PubMed |
| High expression of CHEK2 promotes tumor progression in kidney renal clear cell carcinoma through targeting TEAD4 signaling pathway. | Cell Signal | 2025 | 40653042 | PubTator, text mining | PubMed |
| Hippo Pathway Dysregulation in Thymic Epithelial Tumors (TETs): Associations with Clinicopathological Features and Patients' Prognosis. | Int J Mol Sci | 2025 | 40649713 | PubTator, text mining | PubMed |
| Identification of transcription factors that regulate placental sFLT1 expression. | Mol Hum Reprod | 2025 | 40632597 | PubTator, text mining | PubMed |
| H3K79 methylation and H3K36 trimethylation synergistically regulate gene expression in pluripotent stem cells. | Sci Adv | 2025 | 40614207 | PubTator, text mining | PubMed |
| Hypoxia preconditioned MSC exosomes attenuate high-altitude cerebral edema via the miR-125a-5p/RTEF-1 axis to protect vascular endothelial cells. | Bioact Mater | 2025 | 40599343 | PubTator, text mining | PubMed |
| TEAD4-mediated upregulation of LPAR3 augments hepatic stellate cell activation in portal hypertension. | Cell Biol Toxicol | 2025 | 40591004 | PubTator, text mining | PubMed |
| From Concepts to Inhibitors: A Blueprint for Targeting Protein-Protein Interactions. | Chem Rev | 2025 | 40553022 | PubTator, text mining | PubMed |
| Hydrogel Enhanced Organoid Multidirectional Differentiation via Yap/Tead4 Mechanotransduction for Accelerated Tissue Regeneration. | ACS Appl Mater Interfaces | 2025 | 40550785 | PubTator, text mining | PubMed |
| Expression of Hippo Pathway Molecules in Distal Bile Duct Cancer. | Appl Immunohistochem Mol Morphol | 2025 | 40439084 | PubTator, text mining | PubMed |
| HighPlay: Cyclic Peptide Sequence Design Based on Reinforcement Learning and Protein Structure Prediction. | J Med Chem | 2025 | 40406858 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7004/papers?page=6